Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshihiro Mizumoto is active.

Publication


Featured researches published by Toshihiro Mizumoto.


Archives of Dermatological Research | 1985

Pig-skin epidermal calmodulin: Effects of antagonists of calmodulin on DNA synthesis of pig-skin epidermis

Hajime Iizuka; Yoshio Hashimoto; Masaki Hirokawa; Shinobu Matsuo; Toshihiro Mizumoto; Akira Ohkawara

SummaryAlthough epidermal keratinocytes contain significant amounts of calmodulin, the exact role of calmodulin in epidermal biological activity remains to be determined. Pig-skin (epidermal) calmodulin was purified to homogeneity by DEAE/Sepharose- and phenothiazine-affinity-column chromatography. The characteristics of the purified calmodulin proved to be in good agreement with those of calmodulin obtained from other sources. Phenothiazines (trifluoperazine and chlorpromazine), mepacrine, propranolol, and colchicine inhibited the effect of the purified epidermal calmodulin on the calmodulin-deficient phosphodiesterase of bovine heart. These calmodulin antagonists all had inhibitory effects on the thymidine incorporation of pig-skin epidermal keratinocytes. These observations support the assumption that calmodulin might play an important role in epidermal keratinocyte proliferation.


European Journal of Dermatology | 2012

Livedoid vasculopathy; favorable clinical response with low dose warfarin

Satoshi Nakamura; Mari Kishibe; Kaoru Nishi; Yoshio Hashimoto; Keiko Takeda; Toshihiro Mizumoto; Hajime Iizuka

ejd.2011.1529 Auteur(s) : Satoshi Nakamura1,2 [email protected], Mari Kishibe2, Kaoru Nishi1, Yoshio Hashimoto1, Keiko Takeda2, Toshihiro Mizumoto1, Hajime Iizuka2 1 Asahikawa Kousei Hospital, Department of Dermatology, 1-joudori 24-chome 111, Asahikawa Hokkaido, Japan 2 Asahikawa Medical University, Department of Dermatology, Asahikawa Hokkaido, Japan Livedoid vasculopathy (LV) is a chronic, recurrent, painful skin disorder involving distal lower extremities. LV is induced by coagulation [...]


American Journal of Dermatopathology | 2012

Two cases of male nipple leiomyoma: idiopathic leiomyoma and gynecomastia-associated leiomyoma.

Satoshi Nakamura; Yoshio Hashimoto; Keiko Takeda; Kaoru Nishi; Akemi Ishida-Yamamoto; Toshihiro Mizumoto; Hajime Iizuka

We describe 2 cases of male nipple leiomyoma. A 70-year-old man had a painful subcutaneous tumor on his left nipple of 6 months duration. Histopathology disclosed dermal spindle cells with oval-shaped nuclei forming interlacing bundles with irregular pattern. Glandular elements were absent. The spindle cells were positive to α-smooth muscle actin, desmin, and vimentin. Estrogen receptor (ER) and progesterone receptor (PrR) were negative. We diagnosed this case as male leiomyoma of the nipple. Another patient was a 61-year-old man with gynecomastia induced by spironolactone of 6 months duration. He also had a painful nodule on his left nipple and histopathology disclosed spindle-shaped tumor cells as in the previous patient. The tumor was accompanied by glandular elements in the deep dermis and subcutaneous tissue, which showed apocrine secretion and were positive for α-smooth muscle actin, ER, and PrR. These glandular elements were interpreted as mammary gland. But ER and PrR stain did not show positive results for leiomyoma in the upper dermis. To the best of our knowledge, this is the first report of male idiopathic and gynecomastia-induced leiomyoma with ER and PrR staining.


Journal of Dermatology | 1974

The action of topical vitamin A acid on normal epidermis and non-involved epidermis of psoriatics. A morphological and enzymatic study.

Toshihiro Mizumoto; Takashi Aoyagi; Akira Ohkawara; Yusho Miura

Topical application under occlusion of 0.1% Vitamin A Acid (VAA) in polyethylene glycol to the non‐involved skin of psoriatics and to the skin of normal controls resulted in keratolysis, acanthosis, glycogen accumulation, and increased enzyme activity, though the changes are more marked in the former. Those changes occurred during the first week of application and did not progress further, in fact continued application resulted in a biochemical return toward normal.


Journal of clinical & experimental dermatology research | 2013

Levels of Tumor Necrosis Factor-Alpha, Interleukin-6, and Interferon- Gamma during the Active Phases of Bechet’s Disease, Pustular Psoriasis, Palmoplantar Pustulosis, and Stevens-Johnson Syndrome: A Pilot Study

Satoshi Nakamura; Keiko Takeda; Yoshio Hashimoto; Toshihiro Mizumoto; Hajime Iizuka; Demitsu Toshio

Inflammatory serum cytokines are produced by lymphocytes and target organs in inflammatory skin diseases. Changes in cytokines fluctuate daily during disease activity. Comparisons of serum cytokine levels, cytokine species, or flow cytometric changes during the disease course might not be adequate. In addition, daily target organ examinations are difficult. In this report, we determined disease-specific cytokine balances by continuously measuring the levels of inflammatory cytokines (Interleukin-6 [IL-6], interferon gamma [IFN-gamma], and Tumor Necrosis Factor-alpha [TNFalpha, TNF-a]) in patients with Bechet’s Disease (BD), Pustular Psoriasis (PP), Palmoplantar Pustulosis (PPP), and Stevens-Johnson Syndrome (SJS) during the course of the disease activity. We compared these cytokines in various cutaneous inflammatory diseases activities. Furthermore, participations of inflammatory lymphocytes subsets were considered.


Journal of Dermatological Treatment | 2012

Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis

Satoshi Nakamura; Keiko Takeda; Yoshio Hashimoto; Kaoru Nishi; Hidetoshi Takahashi; Toshihiro Mizumoto; Hajime Iizuka

Abstract Although ciclosporin is useful for atopic dermatitis (AD), appropriate dosage and therapeutic drug monitoring (TDM) has been performed only by post-prandial ciclosporin administration. We administered ciclosporin pre-prandially to eight severe adult AD patients (four cases of erythrodermic AD, three cases of AD recalcitrant to standard therapy, and one AD case with numerous pruriginous lesions). Blood concentrations of ciclosporin at various dosages were measured and appropriate dosage in terms of therapeutic efficacy was analyzed by using the area under the concentration curve (AUC). AUC was estimated by the C1 (obtained serum concentration of ciclosporin at 1 hour after ciclosporin administration), C2 (concentration of ciclosporin at 2 hours) and C4 (concentration of ciclosporin at 4 hours) concentrations of ciclosporin. The trough levels of ciclosporin with 200 mg/day, 150 mg/day, and 100 mg/day administration were 96.5 ng/ml, 66.4 ng/ml, and 75.3 ng/ml, respectively. The peak serum concentration (Cmax) was obtained at 1 hour (C1) in most cases. The AUC of 0–4 hours (AUC 0–4) were 2099.5 ng · h/ml (200 mg/day), 1782.6 ng · h/ml (150 mg/day) and 1696.2 ng · h/ml (100 mg/day). VAS scores of itching and blood eosinophil counts were decreased significantly by the ciclosporin treatment. Pre-prandial administration of a relatively low dose of ciclosporin for severe atopic dermatitis resulted in a favorable subjective and objective clinical response and the measurement of blood concentration mostly correlated with the effective dosage assessment.


Australasian Journal of Dermatology | 2012

Cutaneous tuberculosis simulating lymphocutaneous sporotrichosis

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Hidetoshi Takahashi; Keiko Takeda; Toshihiro Mizumoto; Hajime Iizuka

1. Geissler S, Dyall-Smith D, Coras B et al. Unique brown star shape on dermatoscopy of generalized Dowling–Degos disease. Australas. J. Dermatol. 2011; 52: 151–3. 2. Ackerman AB. Focal acantholytic dyskeratosis. Arch. Dermatol. 1972; 106: 702–6. 3. Ackerman AB, Chongchitnant N, Sanchez J et al. Histologic Diagnosis of Inflammatory Skin Diseases: An Algorithmic Method Based on Pattern Analysis, 2nd edn. Baltimore, MD: Williams and Wilkins, 1997; 421–9. 807–9. 4. Zalaudek I, Kreusch J, Giacomel J et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Non-melanocytic skin tumors. J. Am. Acad. Dermatol. 2010; 63: 377–86. 5. Vázquez-López F, Lopez-Escobar M, Maldonado-Seral C et al. The handheld dermoscope improves the recognition of giant pseudocomedones in Darier’s disease. J. Am. Acad. Dermatol. 2004; 50: 454–5.


Acta Dermato-venereologica | 2012

Cutaneous Lymphangitis Carcinomatosis Metastasis of Extra-ovarian Primary Peritoneal Carcinoma

Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Toshihiro Mizumoto; Hidetoshi Takahashi; Hajime Iizuka

© 2012 The Authors. doi: 10.2340/00015555-1450 Journal Compilation


Journal of Dermatology | 1984

CALMODULIN ACTIVITY IN THE PSORIATIC EPIDERMIS

Yoshiyuki Kusakabe; Hajime Iizuka; Shinobu Matsuo; Satoshi Kajita; Masato Tsutsui; Toshihiro Mizumoto; Akira Ohkawara; Takashi Yamauchi

Recent reports suggest there is a growth‐associated fluctuation of calmodulin content in various tissues. Since psoriatic epidermis is one of the most proliferative epidermal tissues, we studied the calmodulin content of psoriatic involved and uninvolved epidermis.


Journal of Dermatology | 1990

Reversible Inhibition of Keratinocyte Thymidine Incorporation by the Calmodulin Antagonist, W-7

Masaki Hirokawa; Yoshio Hashimoto; Noritaka Ohkuma; Toshihiro Mizumoto; Hajime Iizuka

Although calmodulin has been suggested as an important regulator of keratinocyte proliferation, its precise role remains unknown. We employed a calmodulin antagonist, N‐(6‐aminohexyl)‐5‐chloro‐1‐naphthalenesulfonamide (W‐7), to examine the role of calmodulin on keratinocyte proliferation. N‐(6‐aminohexyl)‐1‐naphthalenesulfonamide (W‐5), a chlorine‐deficient analogue of W‐7 with little anti‐calmodulin activity, was used as the control. W‐7 markedly inhibited thymidine incorporation of pig epidermis at concentrations close to its anti‐calmodulin activity; W‐5 had no effect on the thymidine incorporation. The inhibitory effect of W‐7 was reversible; the removal of W‐7 from the incubation medium resulted in the reinitiation of the thymidine incorporation, suggesting that W‐7 is not a cytotoxic agent. These results are consistent with the view that calmodulin is an essential regulator of keratinocyte proliferation. The epidermal beta‐adrenergic response, which is decreased in various hyperproliferative epidermal abnormalities, was increased in W‐7‐treated hypoproliferative epidermis. The epidermal SOD activity, which is also decreased in the hyperproliferative epidermis, however, was not affected by the W‐7 treatment.

Collaboration


Dive into the Toshihiro Mizumoto's collaboration.

Top Co-Authors

Avatar

Hajime Iizuka

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Ohkawara

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar

Kaoru Nishi

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Keiko Takeda

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaki Hirokawa

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar

Noritaka Ohkuma

Asahikawa Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge